Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial

BACKGROUND: Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a leading cause of death worldwide. The clinical utility of commonly used lipid-lowering drugs such as statins and fibrates is sometimes limited by the occurrence of various adverse reactions. Recently, be...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ying, Yang, Yuan-Yuan, Yang, Bao-Lin, Du, Ya-Wei, Ren, Da-Wei, Zhou, Hong-Mei, Wang, Jing, Yang, Hui-Min, Wang, Yao-Xian, Zhang, Ying-Ying, Wu, Sheng-Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825207/
https://www.ncbi.nlm.nih.gov/pubmed/33482853
http://dx.doi.org/10.1186/s13063-021-05028-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825207/
https://www.ncbi.nlm.nih.gov/pubmed/33482853
http://dx.doi.org/10.1186/s13063-021-05028-8

Ejemplares similares